Literature DB >> 14782975

Central retinal vein thrombosis and hemorrhagic glaucoma.

P BRAENDSTRUP.   

Abstract

Entities:  

Keywords:  CENTRAL RETINAL VEIN; GLAUCOMA; THROMBOSIS

Mesh:

Year:  1950        PMID: 14782975

Source DB:  PubMed          Journal:  Acta Ophthalmol Suppl        ISSN: 0065-1451


× No keyword cloud information.
  8 in total

Review 1.  Central retinal vein occlusion: what's the story?

Authors:  T H Williamson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

2.  Hypotony and experimental rubeosis iridis in primate eyes. A clinicopathologic study.

Authors:  G A Peyman; M Raichand; C P Juarez; S Reinglass; E John
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

3.  Experimental retinal vascular occlusion. II. A clinico-pathologic correlative study of simultaneous occlusion of central retinal vein and artery.

Authors:  C P Juarez; M O Tso; W A van Heuven; M S Hayreh; S S Hayreh
Journal:  Int Ophthalmol       Date:  1986-05       Impact factor: 2.031

4.  Proliferative retinopathy in non-diabetic patients.

Authors:  P H Madsen
Journal:  Doc Ophthalmol       Date:  1971-05-14       Impact factor: 2.379

5.  [Corticosteroids and hemorrhagic glaucoma after central venous occlusion].

Authors:  A Tarkkanen; C Raitta; S Vannas
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1967

6.  Central and hemicentral retinal vein occlusion: role of anti-platelet aggregation agents and anticoagulants.

Authors:  Sohan Singh Hayreh; Patricia A Podhajsky; M Bridget Zimmerman
Journal:  Ophthalmology       Date:  2011-06-24       Impact factor: 12.079

Review 7.  Photocoagulation in retinal vein occlusion.

Authors:  S C Sedney
Journal:  Doc Ophthalmol       Date:  1976-01-28       Impact factor: 2.379

8.  Xenon arc panretinal photocoagulation for central retinal vein occlusion: a randomised prospective study.

Authors:  D R May; M L Klein; G A Peyman; M Raichand
Journal:  Br J Ophthalmol       Date:  1979-11       Impact factor: 4.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.